NCT07295132 2025-12-19
RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse)
Asan Medical Center
Phase 2 Not yet recruiting
Clinical Trials
5 trialsNCT06014528 2025-04-30
IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer
InxMed (Shanghai) Co., Ltd.
Phase 2 Recruiting
NCT04175470 2025-01-03
Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer
Vejle Hospital
Phase 2 Completed
NCT01332656 2015-12-21
OPSALIN
Sanofi
Phase 2 Completed
NCT01485848 2014-06-10
ESP2011-002
Esperance Pharmaceuticals Inc
Phase 2 Completed